Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist. A case report

Am J Obstet Gynecol. 1992 Aug;167(2):515-6. doi: 10.1016/s0002-9378(11)91445-8.

Abstract

To our knowledge, this is the first report of documented growth regression of leiomyomatosis peritonei while the patient was receiving a gonadotropin-releasing hormone agonist. This further documents the role of gonadal steroids in the growth of this tumor.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Gonadotropin-Releasing Hormone / physiology
  • Humans
  • Leiomyoma / drug therapy*
  • Leiomyoma / pathology
  • Leiomyoma / surgery
  • Leuprolide / therapeutic use*
  • Neoplasms, Multiple Primary*
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneal Neoplasms / pathology
  • Peritoneal Neoplasms / surgery

Substances

  • Gonadotropin-Releasing Hormone
  • Leuprolide